DEA Schedule CIII
Strength
5.7; 1.4 mg/1; mg/1
Manufacturer
Orexo US, Inc.NDC
54123095730
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
SUBLINGUAL
Last Updated
1/1/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA204242On Market Since
7/4/2013
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
CONTRAVE ER 8-90 MG TABLET
Brand
51267089099•Nalpropion Pharmaceuticals LLC
$4.9810
per EA
BELBUCA 150 MCG FILM
Brand
59385002260•BioDelivery Sciences International Inc
$7.5560
per EA
BELBUCA 75 MCG FILM
Brand
59385002160•BioDelivery Sciences International Inc
$7.5635
per EA
SUBOXONE 4 MG-1 MG SL FILM
Brand
12496120403•Indivior Inc.
$8.5848
per EA
SUBOXONE 8 MG-2 MG SL FILM
Brand
12496120803•Indivior Inc.
$8.5983
per EA
BELBUCA 300 MCG FILM
Brand
59385002360•BioDelivery Sciences International Inc
$11.8705
per EA
MOVANTIK 12.5 MG TABLET
Brand
82625880101•Valinor Pharma, LLC
$14.6029
per EA
MOVANTIK 25 MG TABLET
Brand
57841130101•RedHill Biopharma Ltd
$14.6309
per EA
MOVANTIK 25 MG TABLET
Brand
57841130103•RedHill Biopharma Ltd
$14.6309
per EA